| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | VZ | United States | $44.44 | $138,191,000,000.00 | Buy | 13 | 2000 |
#2 | T | United States | $26.21 | $125,648,000,000.00 | Buy | 20 | N/A |
#3 | SNY | France | $47.08 | $54,850,299,422.00 | Buy | 6 | N/A |
#4 | BN | Canada | $45.57 | $76,933,000,000.00 | Strong Buy | 7 | N/A |
#5 | CMCSA | United States | $29.83 | $123,707,000,000.00 | Buy | 22 | 1972 |
#6 | BAM | United States | $49.70 | $4,486,000,000.00 | Buy | 11 | N/A |
#7 | NU | Brazil | $17.82 | $6,360,698,000.00 | Buy | 9 | 2021 |
#8 | EPD | United States | $33.25 | $53,004,000,000.00 | Buy | 12 | 1998 |
#9 | CSX | United States | $37.69 | $14,092,000,000.00 | Buy | 21 | N/A |
#10 | KMI | United States | $30.53 | $16,937,000,000.00 | Buy | 12 | 2011 |
#11 | VALE | Brazil | $16.02 | $40,027,019,862.00 | Buy | 8 | N/A |
#12 | AMX | Mexico | $20.69 | $51,012,503,011.00 | Buy | 6 | 2001 |
#13 | ET | United States | $18.45 | $79,757,000,000.00 | Buy | 11 | 2006 |
#14 | SLB | United States | $48.49 | $35,708,000,000.00 | Strong Buy | 19 | N/A |
#15 | WBD | United States | $27.57 | $37,863,000,000.00 | Buy | 21 | N/A |
#16 | CMG | United States | $38.96 | $11,787,400,000.00 | Buy | 27 | 2006 |
#17 | EXC | United States | $44.70 | $24,317,000,000.00 | Buy | 13 | N/A |
#18 | CPNG | United States | $20.17 | $33,664,000,000.00 | Strong Buy | 5 | 2021 |
#19 | JD | China | $28.57 | $183,136,729,092.00 | Buy | 10 | 2014 |
#20 | CUK | United States | $29.82 | $26,622,000,000.00 | Strong Buy | 20 | 2000 |
#21 | GFI | South Africa | $49.93 | $6,555,200,000.00 | Buy | 7 | 2007 |
#22 | MDLN | United States | $44.03 | $27,429,000,000.00 | Buy | 22 | 2025 |
#23 | KDP | United States | $27.40 | $16,174,000,000.00 | Buy | 17 | 1993 |
#24 | KGC | Canada | $31.47 | $6,443,900,000.00 | Strong Buy | 5 | N/A |
#25 | PCG | United States | $15.38 | $24,762,000,000.00 | Buy | 9 | N/A |
#26 | CCL | United States | $30.06 | $26,622,000,000.00 | Strong Buy | 20 | 1987 |
#27 | KVUE | United States | $17.39 | $15,006,000,000.00 | Buy | 12 | 2023 |
#28 | VICI | United States | $27.99 | $3,969,078,000.00 | Buy | 15 | N/A |
#29 | FITB | United States | $49.98 | $8,355,000,000.00 | Buy | 17 | N/A |
#30 | TEVA | Israel | $33.98 | $17,258,000,000.00 | Strong Buy | 8 | N/A |
#31 | HBAN | United States | $17.42 | $7,703,000,000.00 | Buy | 17 | N/A |
#32 | STM | Netherlands | $27.89 | $11,800,000,000.00 | Buy | 6 | 1994 |
#33 | HAL | United States | $33.58 | $22,184,000,000.00 | Buy | 16 | N/A |
#34 | FE | United States | $47.28 | $14,283,000,000.00 | Buy | 15 | N/A |
#35 | TME | China | $16.84 | $4,455,416,345.00 | Strong Buy | 6 | 2018 |
#36 | CNP | United States | $39.69 | $9,114,000,000.00 | Buy | 12 | N/A |
#37 | PPL | United States | $36.25 | $8,979,000,000.00 | Buy | 8 | N/A |
#38 | DVN | United States | $40.12 | $16,554,000,000.00 | Buy | 20 | N/A |
#39 | KEY | United States | $21.57 | $7,007,000,000.00 | Buy | 14 | N/A |
#40 | VIV | Brazil | $14.19 | $10,989,199,704.00 | Buy | 4 | 1998 |
#41 | GMAB | Denmark | $32.58 | $3,845,670,022.00 | Strong Buy | 6 | N/A |
#42 | SW | Ireland | $41.73 | $31,138,000,000.00 | Strong Buy | 11 | N/A |
#43 | TS | Luxembourg | $44.40 | $11,831,250,000.00 | Buy | 4 | N/A |
#44 | BEKE | China | $18.80 | $14,540,474,652.00 | Strong Buy | 5 | 2020 |
#45 | CTRA | United States | $28.80 | $6,666,000,000.00 | Buy | 16 | 1990 |
#46 | NI | United States | $44.30 | $6,327,100,000.00 | Buy | 9 | N/A |
#47 | HL | United States | $22.45 | $1,224,563,000.00 | Buy | 7 | N/A |
#48 | GRAB | Singapore | $4.34 | $3,228,000,000.00 | Strong Buy | 4 | N/A |
#49 | AMCR | Switzerland | $44.19 | $17,401,000,000.00 | Strong Buy | 7 | N/A |
#50 | PINS | United States | $22.04 | $4,056,550,000.00 | Buy | 27 | 2019 |
The FinQuota filters have identified what they believe to be the "Best Blue Chip Stocks Under $50 (February 2026) | FinQuota" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.